Martin J. Driscoll, Chief Executive Officer at JAVELIN PHARMACEUTICALS, INC (JAV), bought 6,331 shares at $1.27 ($8K) on 2010-02-12, disclosed to the SEC on 2010-03-26.
Open-market purchase of $8k JAV by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SBPH | BUY | 2019-05-29 | $60K | — | Filing → |
| SBPH | BUY | 2019-05-22 | $33K | — | Filing → |
| SBPH | BUY | 2019-04-30 | $73K | — | Filing → |